Systemic immunological biomarkers of clinical responses in immune checkpoint blockade therapies.

Abstract

Hugo Arasanz‡ ,1,2, Miren Zuazo‡ ,1, Ruth Vera*,2, Grazyna Kochan**,1 & David Escors***,1,3 1Immunomodulation Group, Navarrabiomed-Fundación Miguel Servet, IdISNA, Complejo Hospitalario de Navarra (CHN), Irunlarrea 3, 31008 Pamplona, Navarra, Spain 2Department of Oncology, Complejo Hospitalario de Navarra (CHN), Irunlarrea 3, 31008 Pamplona, Navarra, Spain 3Division of Infection & Immunity, Rayne Institute, University College London, 5 University Street, London WC1E 6JF, UK *Author for correspondence: ruth.vera.garcia@navarra.es **Author for correspondence: grazyna.kochan@navarra.es ***Author for correspondence: descorsm@navarra.es ‡Authors contributed equally